ArticleCHEST pulmonary2025
Non-Small Cell Lung Cancer Survival by Race and Ethnicity in California, 2014-2019 Differences by Sex and Smoking History.
Article in CHEST pulmonary, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Predicting targeted therapy resistance in non-small cell lung cancer using multimodal machine learning.Journal of thoracic disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is currently the leading cause of cancer-related death. There are gaps in knowledge regarding survival patterns according to sex and smoking status across racial and ethnic groups. Research Question: Are there mortality differences according to race/ethnicity among individuals diagnosed with lung cancer in California when stratified by sex and smoking status? Study Design and Methods: Non-small cell lung cancer (NSCLC) cases diagnosed from 2014 through 2019 from the California Cancer Registry, a population-based cancer surveillance system, were analyzed. Using Cox regression models, hazard ratios (HRs) were estimated for NSCLC mortality according to race and ethnicity, stratified by sex and smoking status and adjusted for sociodemographic and clinical variables. Results: Among 28,854 female individuals, every racial and ethnic group had an HR < 1 compared with non-Hispanic White (NHW) individuals, with the exception of Native Hawaiian and Pacific Islander and American Indian and Alaskan Native (AIAN) populations, who had comparable mortality. Non-Hispanic Black, Hispanic, and Chinese female individuals had lower mortality relative to NHW female individuals, with HRs of 0.94 (95% CI, 0.89-0.99), 0.89 (95% CI, 0.85-0.93), and 0.82 (95% CI, 0.76-0.88), respectively. Among 29,499 male individuals, every racial and ethnic group exhibited a lower HR, compared with NHW male individuals, with the exception of Japanese (HR, 1.14; 95% CI, 0.99-1.31) and AIAN (HR, 1.15; 95% CI, 0.96-1.38) male individuals. Vietnamese female individuals who had never smoked had lower mortality (HR, 0.80; 95% CI, 0.69-0.92) relative to NHW female individuals. Chinese male individuals who had never smoked had lower mortality (HR, 0.83; 95% CI, 0.71-0.97) compared with NHW male individuals who had never smoked. Interpretation: In this population-based study of NSCLC, we found mortality differences across racial/ethnic groups when accounting for sex and smoking status. Further research focused on mortality differences in NSCLC stratified according to race and ethnicity should focus on social determinants of health and health care access factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.